OSUR OraSure Technologies Inc

OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2009 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 12, 2009, at the Historic Hotel Bethlehem, Bethlehem, Pennsylvania. Stockholder proposals must be received no later than December 9, 2008, in order to be considered for inclusion in the Company�s Proxy Statement under relevant Securities and Exchange Commission rules and no later than February 11, 2009, in order to be considered at the Annual Meeting or to nominate a Director under OraSure Technologies� Bylaws. About OraSure Technologies OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians� offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pa., the company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. For more information on the Company, please go to www.orasure.com.